The impact of induction chemotherapy on the outcome of second-line therapy with pemetrexed or docetaxel in patients with advanced non-small-cell lung cancer. [electronic resource]
Producer: 20070810Description: 453-60 p. digitalISSN:- 0923-7534
- Adult
- Aged
- Aged, 80 and over
- Antimetabolites, Antineoplastic -- therapeutic use
- Antineoplastic Agents, Phytogenic -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Docetaxel
- Female
- Glutamates -- therapeutic use
- Guanine -- analogs & derivatives
- Humans
- Kaplan-Meier Estimate
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Neoplasm Staging
- Pemetrexed
- Proportional Hazards Models
- Research Design
- Retrospective Studies
- Sex Factors
- Taxoids -- therapeutic use
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.